Blog RSS Blog.

The Aftermath of Charlottesville: What’s a bioethicist to do?


by Craig Klugman, Ph.D.

Figuring out how to respond to one of the most egregious displays of racism in modern times (U.S.)  is not an easy task. Figuring out what this event means from a bioethics perspective is even more challenging. As anyone in the connected world knows, Mr. Trump explained his support (or at least lack of condemnation) of white nationalists and neo-Nazis in a rally in Charlottesville, Virginia. This progressive city in the south has a long history of bioethics.…

Btn Rss Bioethics News.

Trump’s ‘Emergency’ Declaration For Opioids Could Be A Double-Edged Sword Huffington Post

President Donald Trump said Thursday that he plans to declare the opioid crisis a national emergency. Clearly, the massive increase in drug deaths warrant a serious government response. But what does a national emergency actually mean?

Artificial intelligence identifies plant species for science Nature

Computer algorithms trained on the images of thousands of preserved plants have learned to automatically identify species that have been pressed, dried and mounted on herbarium sheets, researchers report.

Commit to talks on patient data and public health Nature

Of course it was going to happen — and now it has. Last week, an international team reported the use of CRISPR–Cas9 gene-editing techniques to correct a heart-wrenching mutation in human embryos. These attempts worked several times more efficiently than previous ones had, and avoided introducing new genetic errors. Although the embryos were never destined to be used for pregnancies (and have now been destroyed), the work — carried out mainly in the United States — makes it easy to foresee practical applications to genetically alter human embryos.

Horse Clones Start Heading to the Races Bloomberg News

So far, the big winner in the great clone race has been Alan Meeker, chief executive officer of Crestview Genetics. Since 2010 the 52-year-old Texas oil heir has created close to 100 horse clones valued at $500,000 to $800,000 each, depending on how long the company’s raised them.